Manchester Financial Inc Standard Biotools Inc. Transaction History

Manchester Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$4.35 - $6.35 $2,175 - $3,175	-500 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$3.94 - $7.09 $591 - $1,063	-150 Reduced 23.08%	500 $2,000
Q4 2020 Jan 26, 2021	SELL	$5.45 - $8.65 $3,406 - $5,406	-625 Reduced 49.02%	650 $4,000
Q3 2020 Oct 15, 2020	BUY	$4.34 - $11.43 $5,533 - $14,573	1,275 New	1,275 $9,000

143

270M

27.2K

14.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $111M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.